These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 22020956)

  • 1. Validation and application of a death proxy in adult cancer patients.
    Mealing NM; Dobbins TA; Pearson SA
    Pharmacoepidemiol Drug Saf; 2012 Jul; 21(7):742-748. PubMed ID: 22020956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Just Another Statistic".
    Machtay M; Glatstein E
    Oncologist; 1998; 3(3):III-IV. PubMed ID: 10388105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying incident cancer cases in dispensing claims: A validation study using Australia's Repatriation Pharmaceutical Benefits Scheme (PBS) data.
    Daniels B; Tervonen HE; Pearson SA
    Int J Popul Data Sci; 2019 Mar; 5(1):1152. PubMed ID: 32935055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validating a proxy for disease progression in metastatic cancer patients using prescribing and dispensing data.
    Joshi V; Adelstein BA; Schaffer A; Srasuebkul P; Dobbins T; Pearson SA;
    Asia Pac J Clin Oncol; 2017 Oct; 13(5):e246-e252. PubMed ID: 27665738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of delays in treatment for breast cancer metastasis on survival.
    Jung SY; Sereika SM; Linkov F; Brufsky A; Weissfeld JL; Rosenzweig M
    Breast Cancer Res Treat; 2011 Dec; 130(3):953-64. PubMed ID: 21739101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing agreement between terminally ill cancer patients' reports of their quality of life and family caregiver and palliative care physician proxy ratings.
    Jones JM; McPherson CJ; Zimmermann C; Rodin G; Le LW; Cohen SR
    J Pain Symptom Manage; 2011 Sep; 42(3):354-65. PubMed ID: 21454041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation, precision and validity of 1-year survival estimates for lung, breast, colon and prostate cancer in South East England primary care trusts.
    Lake J; Mak V; Møller H; Davies EA
    Public Health; 2012 Jan; 126(1):57-63. PubMed ID: 22153886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of patient and proxy responses on risk factors for stroke.
    Capelle LG; Vlak MH; Algra A; Rinkel GJ
    Acta Neurol Scand; 2011 Mar; 123(3):160-6. PubMed ID: 20545632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Palliative chemotherapy in elderly patients with common metastatic malignancies: A Hellenic Cooperative Oncology Group registry analysis of management, outcome and clinical benefit predictors.
    Pentheroudakis G; Fountzilas G; Kalofonos HP; Golfinopoulos V; Aravantinos G; Bafaloukos D; Papakostas P; Pectasides D; Christodoulou C; Syrigos K; Economopoulos T; Pavlidis N;
    Crit Rev Oncol Hematol; 2008 Jun; 66(3):237-47. PubMed ID: 18243010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of proxies in community integration research.
    Cusick CP; Brooks CA; Whiteneck GG
    Arch Phys Med Rehabil; 2001 Aug; 82(8):1018-24. PubMed ID: 11494179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statistical Uncertainty in Paleoclimate Proxy Reconstructions.
    McClelland HLO; Halevy I; Wolf-Gladrow DA; Evans D; Bradley AS
    Geophys Res Lett; 2021 Aug; 48(15):e2021GL092773. PubMed ID: 35860010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyallergy as a Proxy: Premature Yet Promising.
    Jimenez XF; Tesar GE
    Psychosomatics; 2015; 56(5):606-7. PubMed ID: 26362918
    [No Abstract]   [Full Text] [Related]  

  • 15. BMI Not a Good Proxy for Breast Cancer Risk.
    Slomski A
    JAMA; 2019 Feb; 321(8):735. PubMed ID: 30806692
    [No Abstract]   [Full Text] [Related]  

  • 16. Candidate number 2: proxy representation.
    Beck A
    Science; 2001 Oct; 294(5541):306. PubMed ID: 11599537
    [No Abstract]   [Full Text] [Related]  

  • 17. Prognostics by Proxy.
    South Med Rec; 1898 Sep; 28(9):597. PubMed ID: 36026319
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of coordinated care on adherence to antihypertensive medicines among adults experiencing polypharmacy in Australia.
    Lin J; de Oliveira Costa J; Pearson SA; Buckley NA; Brieger D; Schutte AE; Schaffer AL; Falster MO
    J Hypertens; 2024 Jul; 42(7):1248-1255. PubMed ID: 38704239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation study on definition of cause of death in Japanese claims data.
    Ito F; Togashi S; Sato Y; Masukawa K; Sato K; Nakayama M; Fujimori K; Miyashita M
    PLoS One; 2023; 18(3):e0283209. PubMed ID: 36952484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal Indicator of Death for Using Real-World Cancer Patients' Data From the Healthcare System.
    Jang SC; Kwon SH; Min S; Jo AR; Lee EK; Nam JH
    Front Pharmacol; 2022; 13():906211. PubMed ID: 35784684
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.